DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

5.36 0.08 (1.52%)

REAL-TIME: Last trade at

Extended Hours: $5.36 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

AVNR $5.36 1.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.32
Previous Close $5.28
Daily Range $5.30 - $5.46
52-Week Range $2.62 - $6.00
Market Cap $856.7M
P/E Ratio -11.23
Dividend (Yield) $0.00 (0.0%)
Volume 1,382,457
Average Daily Volume 2,117,317
Current FY EPS -$0.29

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary Rss Feed

Avanir Pharmaceuticals Inc.: What Investors Must Watch in 2014

A big mid-stage disappointment sent Avanir's (AVNR) shares tumbling, but the future may not be as bad as some fear.

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

3 Biotech Stocks Under $10 to Trade for Breakouts

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog

3 Health Care Stocks Under $10 to Trade for Breakouts

AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment of Migraine

Avanir Gains - AVP-825 Hits Phase III Primary Endpoint - Analyst Blog

Morning Market Movers

Benzinga's Top #PreMarket Gainers

Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session - Tale of the Tape

Patients Enrolled in Avanir Study - Analyst Blog

See More AVNR News...

AVNR's Top Competitors

AVNR $5.36 (1.52%)
Current stock: AVNR
JNJ $102.19 (-0.27%)
Current stock: JNJ
NVS $89.02 (-0.27%)
Current stock: NVS
RHHBY $36.82 (-0.03%)
Current stock: RHHBY